Sentry Investment Management’s Cognizant CTSH Stock Holding History

Sentry Investment Management’s Portfolio CTSH Stock Details CTSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,137	Closed	-$94K	–	122
2025 Q4	$94K	Hold	1,137	–	–	0.06%	248
2025 Q3	$78K	Sell	1,137 -386	-25%	-$27.9K	0.05%	284
2025 Q2	$123K	Buy	+1,523	New	+$117K	0.07%	247
2025 Q1	–	Sell	-1,989	Closed	-$153K	–	490
2024 Q4	$153K	Buy	+1,989	New	+$156K	0.07%	226
2023 Q4	–	Sell	-2,933	Closed	-$199K	–	476
2023 Q3	$199K	Sell	2,933 -467	-14%	-$32.2K	0.1%	217
2023 Q2	$222K	Hold	3,400	–	–	0.08%	248
2023 Q1	$207K	Sell	3,400 -123	-3%	-$7.7K	0.09%	246
2022 Q4	$201K	Hold	3,523	–	–	0.09%	244
2022 Q3	$202K	Hold	3,523	–	–	0.1%	220
2022 Q2	$238K	Sell	3,523 -686	-16%	-$52.5K	0.11%	194
2022 Q1	$377K	Buy	4,209 +6	+0.1%	+$527	0.12%	176
2021 Q4	$373K	Hold	4,203	–	–	0.1%	213
2021 Q3	$312K	Sell	4,203 -421	-9%	-$31.1K	0.09%	231
2021 Q2	$320K	Buy	+4,624	New	+$344K	0.08%	242
2020 Q3	–	Sell	-28,897	Closed	-$1.64M	–	438
2020 Q2	$1.64M	Buy	+28,897	New	+$1.55M	0.1%	205
2019 Q4	–	Sell	-7,119	Closed	-$429K	–	442
2019 Q3	$429K	Sell	7,119 -27,277	-79%	-$1.72M	0.03%	392
2019 Q2	$2.18M	Hold	34,396	–	–	0.14%	168
2019 Q1	$2.49M	Sell	34,396 -3,054	-8%	-$214K	0.17%	145
2018 Q4	$2.38M	Sell	37,450 -981	-3%	-$68.2K	0.17%	147
2018 Q3	$2.96M	Hold	38,431	–	–	0.18%	143
2018 Q2	$3.04M	Buy	38,431 +36,196	+1,620%	+$2.85M	0.2%	136
2018 Q1	$180K	Buy	+2,235	New	+$177K	0.01%	454
2017 Q4	–	Sell	-18,864	Closed	-$1.37M	–	477
2017 Q3	$1.37M	Hold	18,864	–	–	0.05%	273
2017 Q2	$1.25M	Sell	18,864 -26,719	-59%	-$1.7M	0.05%	280
2017 Q1	$2.71M	Sell	45,583 -2,105	-4%	-$121K	0.11%	154
2016 Q4	$2.67M	Hold	47,688	–	–	0.11%	160
2016 Q3	$2.27M	Buy	47,688 +1,358	+3%	+$77.3K	0.1%	175
2016 Q2	$2.65M	Hold	46,330	–	–	0.12%	136
2016 Q1	$2.9M	Buy	46,330 +1,147	+3%	+$66.7K	0.13%	126
2015 Q4	$2.71M	Buy	45,183 +11,158	+33%	+$719K	0.13%	136
2015 Q3	$2.13M	Sell	34,025 -10,700	-24%	-$672K	0.11%	156
2015 Q2	$2.73M	Buy	44,725 +1,688	+4%	+$106K	0.13%	142
2015 Q1	$2.69M	Buy	43,037 +6,500	+18%	+$383K	0.13%	134
2014 Q4	$1.92M	Buy	36,537 +9,000	+33%	+$450K	0.09%	168
2014 Q3	$1.23M	Sell	27,537 -3,395	-11%	-$160K	0.06%	216
2014 Q2	$1.51M	Sell	30,932 -2,268	-7%	-$111K	0.08%	195
2014 Q1	$1.68M	Hold	33,200	–	–	0.09%	177
2013 Q4	$1.68M	Buy	33,200 +2,600	+8%	+$118K	0.09%	170
2013 Q3	$1.26M	Buy	30,600 +8,800	+40%	+$327K	0.07%	199
2013 Q2	$683K	Buy	+21,800	New	+$725K	0.04%	229

Other funds holding CTSH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sentry Investment Management's CTSH Position: Q1 2026 in Review

Sentry Investment Management sold out of Cognizant (CTSH) in Q1 2026, closing a stake of 1,137 shares — an estimated $94K sold.

Sentry Investment Management first reported a position in CTSH in Q2 2013 and held it in 40 quarters. The position peaked at $3.04M in Q2 2018. 993 funds tracked by Wall St. Rank hold CTSH as of Q1 2026.

Sentry Investment Management reported no remaining Cognizant position as of Q1 2026 after selling out during the quarter.
Sentry Investment Management sold 1,137 Cognizant shares in Q1 2026, an estimated $94K.
Sentry Investment Management first reported a position in Cognizant in Q2 2013 and held it in 40 quarters.
Sentry Investment Management's Cognizant position peaked at $3.04M in Q2 2018.
993 funds tracked by Wall St. Rank held Cognizant as of Q1 2026.

Based on Sentry Investment Management's 13F filing for Q1 2026, filed 8 May 2026.